Nasal Polyp
0
Pipeline Programs
3
Companies
1
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Applied Medical TechnologyOH - Brecksville
1 programThe Factors Associated With the Formation of Nasal polyp-a Case Control and Descriptive StudyN/A
LabcorpBURLINGTON, NC
1 programThe Factors Associated With the Formation of Nasal polyp-a Case Control and Descriptive StudyN/A
Applied MedicalCA - Rancho Santa Margarita
1 programThe Factors Associated With the Formation of Nasal polyp-a Case Control and Descriptive StudyN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Applied MedicalThe Factors Associated With the Formation of Nasal polyp-a Case Control and Descriptive Study
Clinical Trials (1)
Total enrollment: 180 patients across 1 trials
NCT01278719Applied MedicalThe Factors Associated With the Formation of Nasal polyp-a Case Control and Descriptive Study
The Factors Associated With the Formation of Nasal polyp-a Case Control and Descriptive Study
Start: Jan 2010Est. completion: Jun 2013180 patients
N/AUnknown
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.